137 related articles for article (PubMed ID: 9541080)
1. Colorectal cancer screening: efficiency and effectiveness.
Gyrd-Hansen D; Søgaard J; Kronborg O
Health Econ; 1998 Feb; 7(1):9-20. PubMed ID: 9541080
[TBL] [Abstract][Full Text] [Related]
2. Faecal occult blood screening for colorectal cancer: is it cost-effective?
Whynes DK; Neilson AR; Walker AR; Hardcastle JD
Health Econ; 1998 Feb; 7(1):21-9. PubMed ID: 9541081
[TBL] [Abstract][Full Text] [Related]
3. Analysis of screening data: colorectal cancer.
Gyrd-Hansen D; Søgaard J; Kronborg O
Int J Epidemiol; 1997 Dec; 26(6):1172-81. PubMed ID: 9447396
[TBL] [Abstract][Full Text] [Related]
4. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer.
Lejeune C; Arveux P; Dancourt V; Fagnani F; Bonithon-Kopp C; Faivre J
Eur J Cancer Prev; 2003 Feb; 12(1):77-84. PubMed ID: 12548114
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
6. Filtering strategies in mass population screening for colorectal cancer: an economic evaluation.
Walker A; Whynes DK
Med Decis Making; 1992; 12(1):2-7. PubMed ID: 1538628
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
8. High participation rates are not necessary for cost-effective colorectal cancer screening.
Howard K; Salkeld G; Irwig L; Adelstein BA
J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia.
Salkeld G; Young G; Irwig L; Haas M; Glasziou P
Aust N Z J Public Health; 1996 Apr; 20(2):138-43. PubMed ID: 8799087
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood tests. A cost-effectiveness analysis.
Gyrd-Hansen D
Int J Technol Assess Health Care; 1998; 14(2):290-301. PubMed ID: 9611904
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of colorectal cancer screening in the elderly.
Wagner JL; Herdman RC; Wadhwa S
Ann Intern Med; 1991 Nov; 115(10):807-17. PubMed ID: 1929029
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.
Whynes DK
Crit Rev Oncol Hematol; 1999 Nov; 32(2):155-65. PubMed ID: 10612015
[No Abstract] [Full Text] [Related]
13. The potential benefits and harms of screening for colorectal cancer.
Towler B; Irwig L; Glasziou P; Haas M; Plunkett A; Salkeld G
Aust J Public Health; 1995 Feb; 19(1):24-8. PubMed ID: 7734588
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
Mandel JS; Church TR; Ederer F; Bond JH
J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
[TBL] [Abstract][Full Text] [Related]
15. [Cost of a mass screening program for colorectal cancer using the occult blood test].
Arveux P; Faivre J; Bedenne L; Durand G; Milan C; Milan C
Gastroenterol Clin Biol; 1992; 16(6-7):547-51. PubMed ID: 1526416
[TBL] [Abstract][Full Text] [Related]
16. Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test.
Kronborg O; Fenger C; Worm J; Pedersen SA; Hem J; Bertelsen K; Olsen J
Scand J Gastroenterol; 1992; 27(1):47-52. PubMed ID: 1736342
[TBL] [Abstract][Full Text] [Related]
17. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.
Lejeune C; Arveux P; Dancourt V; Béjean S; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2004; 20(4):434-9. PubMed ID: 15609792
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of colorectal cancer screening strategies.
Tierney WM; Fendrick AM
Gastroenterology; 1996 Jun; 110(6):2026-7. PubMed ID: 8964440
[No Abstract] [Full Text] [Related]
20. [Cost-effectiveness analysis on colorectal cancer screening program].
Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
